Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study

Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, Gordon E Crofoot, Cynthia Brinson, Susan Buchbinder, Jean-Michel Molina, Ronnie M Gravett, James B Brock, Moti N Ramgopal, A Lina Rosengren, Igho Ofotokun, Jose Valdez Madruga, Geoffroy Liegeon, Ravindre Panchia, Khuanchai Supparatpinyo, Anchalee Avihingsanon, Catherine Creticos, Shobha Swaminathan, Susanne Doblecki-Lewis, Jorge Rodriguez, Marc Siegel, Shinichi Oka, Thanyawee Puthanakit, Beatriz Grinsztejn, Eduard J Sanders, Javier R Lama, Johannes Lombaard, Nkosiphile Ndlovu, Peggy Hwang, Jiejun Du, Beth Jackson, Brenda Homony, Barbara Evans, Peter Sklar, Michael N Robertson, Rebeca M Plank

Open source

DOI: 10.1093/cid/ciag171
Published: 2026-03-14
Container: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciag171,
  title = {Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study},
  author = {Raphael J Landovitz and Yvett Pinedo and Federico Hinestrosa and Gordon E Crofoot and Cynthia Brinson and Susan Buchbinder and Jean-Michel Molina and Ronnie M Gravett and James B Brock and Moti N Ramgopal and A Lina Rosengren and Igho Ofotokun and Jose Valdez Madruga and Geoffroy Liegeon and Ravindre Panchia and Khuanchai Supparatpinyo and Anchalee Avihingsanon and Catherine Creticos and Shobha Swaminathan and Susanne Doblecki-Lewis and Jorge Rodriguez and Marc Siegel and Shinichi Oka and Thanyawee Puthanakit and Beatriz Grinsztejn and Eduard J Sanders and Javier R Lama and Johannes Lombaard and Nkosiphile Ndlovu and Peggy Hwang and Jiejun Du and Beth Jackson and Brenda Homony and Barbara Evans and Peter Sklar and Michael N Robertson and Rebeca M Plank},
  year = {2026},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciag171},
  url = {https://doi.org/10.1093/cid/ciag171}
}

RIS

TY  - JOUR
TI  - Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study
AU  - Raphael J Landovitz
AU  - Yvett Pinedo
AU  - Federico Hinestrosa
AU  - Gordon E Crofoot
AU  - Cynthia Brinson
AU  - Susan Buchbinder
AU  - Jean-Michel Molina
AU  - Ronnie M Gravett
AU  - James B Brock
AU  - Moti N Ramgopal
AU  - A Lina Rosengren
AU  - Igho Ofotokun
AU  - Jose Valdez Madruga
AU  - Geoffroy Liegeon
AU  - Ravindre Panchia
AU  - Khuanchai Supparatpinyo
AU  - Anchalee Avihingsanon
AU  - Catherine Creticos
AU  - Shobha Swaminathan
AU  - Susanne Doblecki-Lewis
AU  - Jorge Rodriguez
AU  - Marc Siegel
AU  - Shinichi Oka
AU  - Thanyawee Puthanakit
AU  - Beatriz Grinsztejn
AU  - Eduard J Sanders
AU  - Javier R Lama
AU  - Johannes Lombaard
AU  - Nkosiphile Ndlovu
AU  - Peggy Hwang
AU  - Jiejun Du
AU  - Beth Jackson
AU  - Brenda Homony
AU  - Barbara Evans
AU  - Peter Sklar
AU  - Michael N Robertson
AU  - Rebeca M Plank
PY  - 2026
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciag171
UR  - https://doi.org/10.1093/cid/ciag171
ER  -

APA

Landovitz, R. J., Pinedo, Y., Hinestrosa, F., Crofoot, G. E., Brinson, C., Buchbinder, S., Molina, J., Gravett, R. M., Brock, J. B., Ramgopal, M. N., Rosengren, A. L., Ofotokun, I., Madruga, J. V., Liegeon, G., Panchia, R., Supparatpinyo, K., Avihingsanon, A., Creticos, C., Swaminathan, S., Doblecki-Lewis, S., Rodriguez, J., Siegel, M., Oka, S., Puthanakit, T., Grinsztejn, B., Sanders, E. J., Lama, J. R., Lombaard, J., Ndlovu, N., Hwang, P., Du, J., Jackson, B., Homony, B., Evans, B., Sklar, P., Robertson, M. N., & Plank, R. M. (2026). Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag171

Source records

crossref · retrieved 2026-09-25T15:08:17.764Z